Skip to main content

Treatment of Concominant Conditions Related to DM! (cont.)

 TREATMENT OF CONCOMINANT CONDITIONS RELATED TO DIABETES MELLITUS

  1. Coronary Heart Disease
  2. Dyslipidemia
  3. Hypertension
  4. HIV and AIDS
  5. Antipsychotic Therapy
  6. Hypoglycemia
  7. Diabetic Ketoacidosis (DKA)
  8. Hyperosmolar Hyperglycemic state
  9. Retinopathy
  10. Neuropathy
  11. Foot Ulcers 

3.HYPERTENSION

Uncontrolled blood pressure plays a major role in the development of macrovascular events as well as microvascular complications, including retinopathy and nephropathy in patients with Diabetes Mellitus.

Medications:

There are several other principles regarding the treatment of hypertension in Diabetes patients.

  • Angiotensin-converting enzyme (ACE) inhibitors or Angiotensin II receptor Blockers are recommended as initial therapy because of their beneficial effects on renal function.
  • Combination therapy with ACE Inhibitor and Dihydropyridine calcium channel blockers has shown to reduce cardiovascular morbidity and mortality versus those receiving ACE Inhibitor therapy combined with Thiazide Diuretic.
  • However, thiazide diuretics work synergistically with ACE Inhibitors and angiotensin II receptor blockers and can be added  on for those who fail to reach blood pressure goals with a single agent goal as long as the patients estimated glomerular filtration rate remains at 30mL/min/1.73m2 or higher.
  • Alternatively, a loop diuretic can be used.

Recommended Goals:

  • The ADA recommends that systolic blood pressure goals for patients with DM be individualized but generally set at less than 130mmHg. The diastolic blood pressure goal for patients with DM is less than 80mmHg.
  • It can be expected that most patients require more than one agent to reach blood pressure goal.
  • Renal function and serum potential levels should be monitored closely in all patients taking an ACE inhibitor, Angiotensin II receptor blocker and/or diuretic.

Contraindication:

    • ACE inhibitors and angiotensin II receptor blockers are contraindicated in pregnancy and in those with  bilateral renal therapy.`


4.HUMAN IMMUNODEFICIENCY VIRUS (HIV) and ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)

  • Patients with risk factor for diabetes are more likely to develop diabetes when exposed to highly active antiretroviral therapy.
  • Universal screening for all HIV Patients for diabetes is controversial, but most clinicians support screening for those with risk factors, especially if those risk factors include positive family history and central adiposity.
  • Disturbances in glucose homeostasis are known side effects of protease inhibitor therapy.

Medications:

  • Indinavir and Ritonavir block insulin-mediated glucose disposal causing insulin resistance, but Amprenavir and Atazanavir have no effects on this pathway.
  • Indinavir also increases hepatic glucose production and release and causes insulin to lose its ability to suppress hepatic glucose production.
  • Nelfinavir, lopinavir and Saquinavir causes a 25% reduction in beta-cell function, reducing first-phase insulin release.

Contraindications:

  • Drug selection for treating protease inhibitors-induced hyperglycemia should address the mechanism behind the adverse effects.
  • Protease inhibitor therapy should be avoided in patients with pre-existing glucose abnormalities and in those with a first-degree relative with diabetes.
  • Metformin should be used with caution in patients taking the nucleoside reverse transcriptase inhibitors Stavudine, Zidovudine and Didanosine because of an increased risk for lactic acidemia.

5.ANTIPSYCHOTIC DRUG THERAPY

  • An association has been discovered between the second-generation antipsychotics and the development of diabetes.
  • Risk seems to be the highest with Clozapine and Olanzapine, but data are conflicting for Risperidone and Quetiapine.
  • Aripiprazole and Ziprasione for yet have no shown an increased risk for diabetes with their use.

Recommendations:

  • Nutrition and physical activity counselling is recommended for all patients with mental illness who are overweight or obese, especially if they are second generation anti-psychotics.
  • After the therapy, patients' weight should be assessed at weeks 4, 8, and 12 and then every 3 months.
  • In an event of increase in patients weight greater than or equal to 5%, of the patient's baseline weight, the therapeutic adjustment should be considered.
  • For patients who develop worsening glycemia or Dyslipidemia while on antipsychotic therapy, it is recommended that a switch to second generation antipsychotic with less weight gain or diabetes potential be considered. 

Comments

Popular posts from this blog

Drug-Induced Ototoxicity!

 DRUG-INDUCED OTOTOXICITY What is drug Induced Ototoxicity? Drug-Induced ototoxicity can affect hearing (auditory or cochlear function0, balance (vestibular function) depending on the drug. Drugs of almost every class have been reported to produce tinnitus (sounds in ear), as have placebos. The following agents are associated with measurable changes in hearing or vestibular defect when administered systemically. 1. AMINOGLYCOSIDES: Aminoglycosides antibiotics can cause cochlear or vestibular toxicities. Cochlear toxicity: occurs as progressive hear loss, starting with highest tones and advancing to lower tones. Thus, considerable damage can occur before the patient recognizes it. S ymptoms of Vestibular damage : include;  Dizziness Vertigo Ataxia Both forms of ototoxicity are bilateral and potentially reversible, but permanent damage is common and can progress even after discontinuation of aminoglycosides. Clinically detectable ototoxicity in as many as 5% patients. Most amin...

PNEUMONIA- Its Etiology, Pathophysiology, Classification and Severity Assessment Method!

 PNEUMONIA Definition: "Pneumonia is an infection of pulmonary parenchyma". (Harrison)                                                    OR "Pneumonia is defined as an acute respiratory illness associated with recently developed radiological pulmonary shadowing which may be segmental, lobar or multilobar". (Davidson) Etiology: Microorganisms gain excess to the lower respiratory tract in several ways: Aspiration from the oropharynx (most common). Inhalation of contaminated droplets. Hematogenous spread. Contiguous extension. Pathophysiology of Pneumonia: Pneumonia results from proliferation of microbial pathogens at the alveolar level and the hosts response to these microorganisms.  Defensive Mechanisms against Pneumonia: The defensive mechanism against pneumonia involve: Branching architecture of tracheobronchial tree. Muco-ciliary clearance. Local...

Diabetes Mellitus: Types!

TYPES OF DIABETES MELLITUS 1. TYPE1 DM Type 1 DM is usually diagnosed before age 30 years, but it can develop at any age. T1DM is an autoimmune disease in which insulin producing B-cells are destroyed. The presence of Human Leucocyte Antigens (HLAs ) is associated with the development of T1DM. In addition, these individuals often develop Islet cell antibodies , Insulin Autoantibodies or Glutamic Acid decarboxylase autoantibodies . At the time of development of diagnosis of T1DM, it is usually believed that most of the patients have 80-90%loss of beta cells. The remaining beta cells function at the diagnosis creates a " HONEYMOON PERIOD" during which the blood glucose levels are easier to control, and smaller amounts of insulin are required. after this, the remaining beta cells function is completely lost, and the patients become completely deficient of insulin and hence require exogenous insulin.  2. TYPE1.5 DM:  Also referred as Latent autoimmune diabetes in Adults (LAD) ...